Spire Wealth Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45.1K Buy
540
+292
+118% +$24K ﹤0.01% 1170
2026
Q2
$16.5K Buy
+248
New +$21K ﹤0.01% 1498
2026
Q1
– Sell
-2,236
Closed -$272K – 2403
2025
Q4
$272K Sell
2,236
-2,792
-56% -$350K 0.01% 709
2025
Q3
$564K Sell
5,028
-40
-0.8% -$4.68K 0.02% 497
2025
Q2
$679K Buy
+5,068
New +$556K 0.02% 448

Other funds holding TMDX

Spire Wealth Management's TMDX Position: Q3 2026 in Review

Spire Wealth Management increased its Transmedics (TMDX) stake by 118% in Q3 2026, buying an estimated $24K and bringing the position to 540 shares worth $45.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1170.

Spire Wealth Management first reported a position in TMDX in Q2 2025 and has held it in 5 quarters since. The position peaked at $679K in Q2 2025. 378 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Spire Wealth Management held 540 shares of Transmedics worth $45.1K as of Q3 2026.
  • Spire Wealth Management bought 292 Transmedics shares in Q3 2026, an estimated $24K.
  • Transmedics made up ﹤0.01% of Spire Wealth Management's portfolio in Q3 2026, its #1170 holding.
  • Spire Wealth Management first reported a position in Transmedics in Q2 2025 and has held it in 5 quarters since.
  • Spire Wealth Management's Transmedics position peaked at $679K in Q2 2025.
  • 378 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Spire Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.